Follistatin-like 1: A potential mediator of inflammation in obesity

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Fan, Nengguang ^a,b   Sun, Haiyan ^a   Wang, Yufan ^a   Wang, Yifei ^a   Zhang, Lijuan ^b   Xia, Zhenhua ^b   Peng, Liang ^b   Hou, Yanqiang ^b   Shen, Weiqin ^b   Liu, Rui ^a   Yin, Jiajing ^a   Peng, Yongde ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b Shanghai Songjiang Centeral Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; CYTOKINE; FOLLISTATIN LIKE 1 PROTEIN; I KAPPA B KINASE BETA; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN KINASE B; RECOMBINANT PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; AUTACOID; FOLLISTATIN RELATED PROTEIN; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TOLL LIKE RECEPTOR 4;

ADIPOCYTE; ADIPOSE TISSUE; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FEMALE; GENE EXPRESSION; HUMAN; INFLAMMATION; INSULIN RESISTANCE; MACROPHAGE; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN EXPRESSION; SERUM; SIGNAL TRANSDUCTION; UPREGULATION; 3T3 CELL LINE; ANIMAL; C57BL MOUSE; CYTOLOGY; IMMUNOLOGY; METABOLISM; PHYSIOLOGY;

MUS;

3T3-L1 CELLS; ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; CELL DIFFERENTIATION; FOLLISTATIN-RELATED PROTEINS; HUMANS; I-KAPPA B KINASE; INFLAMMATION; INFLAMMATION MEDIATORS; INSULIN; INSULIN RESISTANCE; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; NF-KAPPA B; OBESITY; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84890041454     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/752519     Document Type: Article

References (48)

1. Franks P. W., Hanson R. L., Knowler W. C., Sievers M. L., Bennett P. H., Looker H. C., Childhood obesity, other cardiovascular risk factors, and premature death. The New England Journal of Medicine 2010 362 6 485 493 2-s2.0-76649086071 10.1056/NEJMoa0904130
2. Dali-Youcef N., Mecili M., Ricci R., Andres E., Metabolic inflammation: connecting obesity and insulin resistance. Annals of Medicine 2013 45 3 242 253
3. Gregor M. F., Hotamisligil G. S., Inflammatory mechanisms in obesity. Annual Review of Immunology 2011 29 415 445 2-s2.0-79953046341 10.1146/annurev-immunol-031210-101322
4. Monteiro R., Azevedo I., Chronic inflammation in obesity and the metabolic syndrome. Mediators of Inflammation 2010 2010 10 2-s2.0-77955362775 10.1155/2010/289645 289645
5. Waki H., Tontonoz P., Endocrine functions of adipose tissue. Annual Review of Pathology 2007 2 31 56 2-s2.0-33947430960 10.1146/annurev.pathol.2. 010506.091859 (Pubitemid 46448059)
6. Tilg H., Moschen A. R., Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nature Reviews Immunology 2006 6 10 772 783 2-s2.0-33748992313 10.1038/nri1937 (Pubitemid 44453463)
7. Ouchi N., Parker J. L., Lugus J. J., Walsh K., Adipokines in inflammation and metabolic disease. Nature Reviews Immunology 2011 11 2 85 97 2-s2.0-79151484704 10.1038/nri2921
8. Deng Y., Scherer P. E., Adipokines as novel biomarkers and regulators of the metabolic syndrome. Annals of the New York Academy of Sciences 2010 1212 E1 E19 2-s2.0-79952259618
9. Miyamae T., Marinov A. D., Sowders D., Wilson D. C., Devlin J., Boudreau R., Robbins P., Hirsch R., Follistatin-like protein-1 is a novel proinflammatory molecule. Journal of Immunology 2006 177 7 4758 4762 2-s2.0-33749131747 (Pubitemid 44469810)
10. Shibanuma M., Mashimo J., Mita A., Kuroki T., Nose K., Cloning from a mouse osteoblastic cell line of a set of transforming-growth factor- β 1-regulated genes, one of which seems to encode a follistatin-related polypeptide. European Journal of Biochemistry 1993 217 1 13 19 2-s2.0-0027431095 10.1111/j.1432-1033.1993.tb18212.x (Pubitemid 23305265)
11. Hambrock H. O., Kaufmann B., Müller S., Hanisch F., Nose K., Paulsson M., Maurer P., Hartmann U., Structural characterization of TSC-36/Flik: analysis of two charge isoforms. The Journal of Biological Chemistry 2004 279 12 11727 11735 2-s2.0-1642441948 10.1074/jbc.M309318200 (Pubitemid 38401677)
12. Liu S., Wang L., Wang W., Lin J., Han J., Sun H., Guo H., Sun R., Wu Q., TSC-36/FRP inhibits vascular smooth muscle cell proliferation and migration. Experimental and Molecular Pathology 2006 80 2 132 140 2-s2.0-33644501780 10.1016/j.yexmp.2005.07.005
13. Ouchi N., Oshima Y., Ohashi K., Higuchi A., Ikegami C., Izumiya Y., Walsh K., Follistatin-like 1, a secreted muscle protein, promotes endothelial cell function and revascularization in ischemic tissue through a nitric-oxide synthase-dependent mechanism. The Journal of Biological Chemistry 2008 283 47 32802 32811 2-s2.0-57749107636 10.1074/jbc.M803440200
14. Chan Q. K. Y., Ngan H. Y. S., Ip P. P. C., Liu V. W. S., Xue W. C., Cheung A. N. Y., Tumor suppressor effect of follistatin-like 1 in ovarian and endometrial carcinogenesis-a differential expression and functional analysis. Carcinogenesis 2009 30 1 114 121 2-s2.0-58949099404 10.1093/carcin/bgn215
15. Oshima Y., Ouchi N., Sato K., Izumiya Y., Pimentel D. R., Walsh K., Follistatin-like 1 is an Akt-regulated cardioprotective factor that is secreted by the heart. Circulation 2008 117 24 3099 3108 2-s2.0-48249155484 10.1161/CIRCULATIONAHA.108.767673
16. Geng Y., Dong Y., Yu M., Zhang L., Yan X., Sun J., Qiao L., Geng H., Nakajima M., Furuichi T., Ikegawa S., Gao X., Chen Y., Jiang D., Ning W., Follistatin-like 1 (Fstl1) is a bone morphogenetic protein (BMP) 4 signaling antagonist in controlling mouse lung development. Proceedings of the National Academy of Sciences of the United States of America 2011 108 17 7058 7063 2-s2.0-79955561301 10.1073/pnas.1007293108
17. Clutter S. D., Wilson D. C., Marinov A. D., Hirsch R., Follistatin-like protein 1 promotes arthritis by up-regulating IFN- γ Journal of Immunology 2009 182 1 234 239 2-s2.0-59849104826
18. Li D., Wang Y., Xu N., Wei Q., Wu M., Li X., Zheng P., Sun S., Jin Y., Zhang G., Liao R., Zhang P., Follistatin-like protein 1 is elevated in systemic autoimmune diseases and correlated with disease activity in patients with rheumatoid arthritis. Arthritis Research and Therapy 2011 13 1, article R17 2-s2.0-79551682286 10.1186/ar3241
19. Wu Y., Zhou S., Smas C. M., Downregulated expression of the secreted glycoprotein follistatin-like 1 (Fstl1) is a robust hallmark of preadipocyte to adipocyte conversion. Mechanisms of Development 2010 127 3-4 183 202 2-s2.0-77950929055 10.1016/j.mod.2009.12.003
20. Chaly Y., Marinov A. D., Oxburgh L., Bushnell D. S., Hirsch R., FSTL1 promotes arthritis in mice by enhancing inflammatory cytokine/chemokine expression. Arthritis and Rheumatism 2012 64 4 1082 1088
21. Murakami K., Tanaka M., Usui T., Kawabata D., Shiomi A., Iguchi-Hashimoto M., Shimizu M., Yukawa N., Yoshifuji H., Nojima T., Ohmura K., Fujii T., Umehara H., Mimori T., Follistatin-related protein/follistatin-like 1 evokes an innate immune response via CD14 and toll-like receptor 4. FEBS Letters 2012 586 4 319 324 2-s2.0-84857051059 10.1016/j.febslet.2012.01.010
22. Ichioka M., Suganami T., Tsuda N., Shirakawa I., Hirata Y., Satoh-Asahara N., Shimoda Y., Tanaka M., Kim-Saijo M., Miyamoto Y., Kamei Y., Sata M., Ogawa Y., Increased expression of macrophage-inducible C-type lectin in adipose tissue of obese mice and humans. Diabetes 2011 60 3 819 826 2-s2.0-79952392892 10.2337/db10-0864
23. Kaiden Student A., Hsu R. Y., Lane M. D., Induction of fatty acid synthetase synthesis in differentiating 3T3-L1 preadipocytes. The Journal of Biological Chemistry 1980 255 10 4745 4750 2-s2.0-0018869666 (Pubitemid 10060752)
24. Wilson D. C., Marinov A. D., Blair H. C., Bushnell D. S., Thompson S. D., Chaly Y., Hirsch R., Follistatin-like protein 1 is a mesenchyme-derived inflammatory protein and may represent a biomarker for systemic-onset juvenile rheumatoid arthritis. Arthritis and Rheumatism 2010 62 8 2510 2516 2-s2.0-77955357723 10.1002/art.27485
25. Hotamisligil G. S., Peraldi P., Budavari A., Ellis R., White M. F., Spiegelman B. M., IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF- α-and obesity-induced insulin resistance. Science 1996 271 5249 665 668 2-s2.0-0030061922 (Pubitemid 26052915)
26. Delerive P., Fruchart J.-C., Staels B., Peroxisome proliferator-activated receptors in inflammation control. Journal of Endocrinology 2001 169 3 453 459 2-s2.0-0034965596 10.1677/joe.0.1690453 (Pubitemid 32536978)
27. Friedman J. M., Halaas J. L., Leptin and the regulation of body weight in mammals. Nature 1998 395 6704 763 770 2-s2.0-0032558725 10.1038/27376 (Pubitemid 28485436)
28. Weisberg S. P., McCann D., Desai M., Rosenbaum M., Leibel R. L., Ferrante A. W. Jr., Obesity is associated with macrophage accumulation in adipose tissue. Journal of Clinical Investigation 2003 112 12 1796 1808 2-s2.0-0348230958 10.1172/JCI200319246 (Pubitemid 38063703)
29. Kanda H., Tateya S., Tamori Y., Kotani K., Hiasa K., Kitazawa R., Kitazawa S., Miyachi H., Maeda S., Egashira K., Kasuga M., MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. Journal of Clinical Investigation 2006 116 6 1494 1505 2-s2.0-33745216724 10.1172/JCI26498
30. Arkan M. C., Hevener A. L., Greten F. R., Maeda S., Li Z., Long J. M., Wynshaw-Boris A., Poli G., Olefsky J., Karin M., IKK- β links inflammation to obesity-induced insulin resistance. Nature Medicine 2005 11 2 191 198 2-s2.0-20044387026 10.1038/nm1185 (Pubitemid 40321355)
31. Hirosumi J., Tuncman G., Chang L., Görgün C. Z., Uysal K. T., Maeda K., Karin M., Hotamisligil G. S., A central, role for JNK in obesity and insulin resistance. Nature 2002 420 6913 333 336 2-s2.0-0037153158 10.1038/nature01137 (Pubitemid 35398190)
32. Stienstra R., Joosten L. A. B., Koenen T., Van Tits B., Van Diepen J. A., Van Den Berg S. A. A., Rensen P. C. N., Voshol P. J., Fantuzzi G., Hijmans A., Kersten S., Müller M., Van Den Berg W. B., Van Rooijen N., Wabitsch M., Kullberg B., Van Der Meer J. W. M., Kanneganti T., Tack C. J., Netea M. G., The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity. Cell Metabolism 2010 12 6 593 605 2-s2.0-78649498271 10.1016/j.cmet.2010.11.011
33. Chacón M. R., Miranda M., Jensen C. H., Fernández-Real J. M., Vilarrasa N., Gutiérrez C., Näf S., Gomez J. M., Vendrell J., Human serum levels of fetal antigen 1 (FA1/Dlk1) increase with obesity, are negatively associated with insulin sensitivity and modulate inflammation in vitro. International Journal of Obesity 2008 32 7 1122 1129 2-s2.0-47249134617 10.1038/ijo.2008.40 (Pubitemid 351986196)
34. Matsubara T., Mita A., Minami K., Hosooka T., Kitazawa S., Takahashi K., Tamori Y., Yokoi N., Watanabe M., Matsuo E., Nishimura O., Seino S., PGRN is a key adipokine mediating high fat diet-induced insulin resistance and obesity through IL-6 in adipose tissue. Cell Metabolism 2012 15 1 38 50 2-s2.0-84855430348 10.1016/j.cmet.2011.12.002
35. Gao D., Trayhurn P., Bing C., 1,25-dihydroxyvitamin D3 inhibits the cytokine-induced secretion of MCP-1 and reduces monocyte recruitment by human preadipocytes. International Journal of Obesity 2013 37 3 357 365 2-s2.0-84859719417 10.1038/ijo.2012.53
36. Hotamisligil G. S., Shargill N. S., Spiegelman B. M., Adipose expression of tumor necrosis factor- α: direct role in obesity-linked insulin resistance. Science 1993 259 5091 87 91 2-s2.0-0027459878 (Pubitemid 23036092)
37. Samad F., Yamamoto K., Pandey M., Loskutoff D. J., Elevated expression of transforming growth factor- β in adipose tissue from obese mice. Molecular Medicine 1997 3 1 37 48 2-s2.0-0031000588 (Pubitemid 27142523)
38. Tanaka M., Ozaki S., Osakada F., Mori K., Okubo M., Nakao K., Cloning of follistatin-related protein as a novel autoantigen in systemic rheumatic diseases. International Immunology 1998 10 9 1305 1314 2-s2.0-0031715096 10.1093/intimm/10.9.1305 (Pubitemid 28414336)
39. Kawabata D., Tanaka M., Fujii T., Umehara H., Fujita Y., Yoshifuji H., Mimori T., Ozaki S., Ameliorative effects of follistatin-related protein/TSC-36/FSTL1 on joint inflammation in a mouse model of arthritis. Arthritis and Rheumatism 2004 50 2 660 668 2-s2.0-1042301977 10.1002/art.20023 (Pubitemid 38198850)
40. Le Luduec J. B., Condamine T., Louvet C., Thebault P., Heslan J.-M., Heslan M., Chiffoleau E., Cuturi M.-C., An immunomodulatory role for follistatin-like 1 in heart allograft transplantation. American Journal of Transplantation 2008 8 11 2297 2306 2-s2.0-53749098815 10.1111/j.1600-6143.2008. 02398.x
41. Solinas G., Karin M., JNK1 and IKK β: molecular links between obesity and metabolic dysfunction. The FASEB Journal 2010 24 8 2596 2611 2-s2.0-77955806634 10.1096/fj.09-151340
42. Janssens S., Beyaert R., Role of toll-like receptors in pathogen recognition. Clinical Microbiology Reviews 2003 16 4 637 646 2-s2.0-0142031430 10.1128/CMR.16.4.637-646.2003 (Pubitemid 37296552)
43. Erridge C., Endogenous ligands of TLR2 and TLR4: agonists or assistants? Journal of Leukocyte Biology 2010 87 6 989 999 2-s2.0-77954005130 10.1189/jlb.1209775
44. Shi H., Kokoeva M. V., Inouye K., Tzameli I., Yin H., Flier J. S., TLR4 links innate immunity and fatty acid-induced insulin resistance. Journal of Clinical Investigation 2006 116 11 3015 3025 2-s2.0-33750584214 10.1172/JCI28898 (Pubitemid 44684486)
45. Schaeffler A., Gross P., Buettner R., Bollheimer C., Buechler C., Neumeier M., Kopp A., Schoelmerich J., Falk W., Fatty acid-induced induction of Toll-like receptor-4/nuclear factor- B pathway in adipocytes links nutritional signalling with innate immunity. Immunology 2009 126 2 233 245 2-s2.0-58149310977 10.1111/j.1365-2567.2008.02892.x
46. Aguirre V., Uchida T., Yenush L., Davis R., White M. F., The c-Jun NH2-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser307. The Journal of Biological Chemistry 2000 275 12 9047 9054 2-s2.0-0034708832 10.1074/jbc.275.12.9047 (Pubitemid 30180265)
47. Copps K. D., White M. F., Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2. Diabetologia 2012 55 10 2565 2582
48. Gao Z., Hwang D., Bataille F., Lefevre M., York D., Quon M. J., Ye J., Serine phosphorylation of insulin receptor substrate 1 by inhibitor B kinase complex. The Journal of Biological Chemistry 2002 277 50 48115 48121 2-s2.0-0037073679 10.1074/jbc.M209459200 (Pubitemid 35470759)